Form 4: GE HealthCare Executive Acquires Stock Options and Restricted Stock Units

Sentiment:

SEC Form 4


Frank R. Jimenez, GC & Corporate Secretary of GE HealthCare Technologies Inc., reports the acquisition of stock options and restricted stock units in the company.

Summary

  • Frank R. Jimenez, GC & Corporate Secretary of GE HealthCare Technologies Inc., filed a Form 4 detailing changes in beneficial ownership.
  • On March 3, 2025, Jimenez was awarded 10,121 restricted stock units (RSUs) and an option to purchase 28,944 shares of GE HealthCare common stock.
  • The RSUs will vest in three tranches: 33% on September 3, 2026, 33% on September 3, 2027, and 34% on September 3, 2028.
  • The stock options also vest in three tranches with the same vesting schedule as the RSUs.
  • Jimenez also disposed of 71,572 shares of common stock.
  • Following these transactions, Jimenez directly owns 28,944 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The stock disposal is a slight negative, but overall, it's a standard corporate action.

Positives

  • The grant of stock options and restricted stock units to a key executive like the GC & Corporate Secretary suggests the company's confidence in its future performance.
  • The vesting schedule aligns the executive's interests with the long-term success of the company.

Negatives

  • The disposal of 71,572 shares of common stock by Jimenez could be interpreted negatively by some investors, although the reason for the disposal is not specified.

Risks

  • The vesting of the stock options and restricted stock units is subject to certain conditions, which are not detailed in the filing.
  • The value of the stock options is dependent on the future performance of GE HealthCare's stock price.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedule of the stock options and RSUs suggests a long-term focus.

Industry Context

Stock option and RSU grants are common practice in the healthcare industry to incentivize and retain key executives. These grants align executive compensation with shareholder value creation.

Comparison to Industry Standards

  • Companies like Siemens Healthineers and Philips also utilize stock options and restricted stock units as part of their executive compensation packages.
  • The vesting schedules and grant sizes are generally comparable to industry standards for similar roles and company sizes.

Stakeholder Impact

  • Shareholders may view the stock option and RSU grants as a positive sign of management's commitment to the company's long-term success.
  • Employees may be motivated by the fact that executives are incentivized to improve the company's performance.

Key Dates

DateDescription
03/03/2025Date of transaction: Award of restricted stock units and employee stock options.
03/05/2025Date of signature on the Form 4 filing.
09/03/2026First vesting date for 33% of the restricted stock units and employee stock options.
09/03/2027Second vesting date for 33% of the restricted stock units and employee stock options.
09/03/2028Final vesting date for 34% of the restricted stock units and employee stock options.
03/03/2035Expiration date of the employee stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.